 |
|
Association of Human Immunodeficiency Virus and Anal Human Papillomavirus Infection Among Homosexual Men
Cathy W. Critchlow, MS;
King K. Holmes, MD, PhD;
Robert Wood, MD;
Leigh Krueger, MPH;
Carol Dunphy, ARNP, MN;
Debra A. Vernon, ASCP;
Janet R. Daling, PhD;
Nancy B. Kiviat, MD
Arch Intern Med. 1992;152(8):1673-1676.
Abstract
| |
Background.—
A previous study of men with proctitis, proctocolitis, or enteritis showed an association of anal human papillomavirus (HPV) infection with human immunodeficiency virus (HIV) infection. Because anorectal abnormalities may confound an observed association between anal HPV DNA and HIV seropositivity, the present study was undertaken among consecutive homosexual men seeking HIV serologic testing who were unselected for anorectal symptoms.
Methods.—
Consecutive homosexual men underwent a standardized interview, physical examination, and collection of specimens for HIV serologic testing and detection of anal HPV DNA.
Results.—
Anal HPV DNA was detected in eight (31%) of 26 HIV-seropositive men and in 10 (8%) of 119 HIV-IVseronegative men (odds ratio, 5.8; 95% confidence interval, 1.1 to 30.1, adjusted for history of sexually transmitted disease, current anorectal symptoms, and age). When men with anorectal symptoms were excluded from the analysis, anal HPV DNA was detected in 27% of seropositive men compared with 8% of seronegative men (odds ratio, 4.4; 95% confidence interval, 1.4 to 13.4). There was no difference between HIV-seropositive and HIV-seronegative men with respect to distribution of type of HPV DNA. Men with group II or III and group IV HIV disease were 4.1 and 10.9 times, respectively, more likely than HIV-seronegative men to have anal HPV DNA detected.
Conclusions.—
Because HIV-seropositive men appear to be at increased risk for the detection of anal HPV DNA, the natural course of anal HPV infection should be compared among HIV-seropositive and HIV-seronegative homosexual men.
(Arch Intern Med. 1992;152:1673-1676)
Author Affiliations
From the Departments of Biostatistics (Ms Critchlow), Epidemiology (Ms Critchlow and Dr Daling), Medicine (Drs Holmes and Wood), and Pathology (Ms Vernon and Dr Kiviat), University of Washington, Seattle, and the Seattle-King County Department of Public Health (Dr Wood and Mss Krueger and Dunphy).
Footnotes
Accepted for publication January 24, 1992.
Reprint requests to Center for AIDS & Sexually Transmitted Diseases, University of Washington, ZH-15, Seattle, WA 98195 (Ms Critchlow).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Treatment of anal human papillomavirus-associated disease: a long term outcome study
Nathan et al.
Int J STD AIDS 2008;19:445-449.
ABSTRACT
| FULL TEXT
Biology of HPV in HIV Infection
Palefsky
ADR 2006;19:99-105.
ABSTRACT
| FULL TEXT
Effect of Anal Epidermoid Cancer-related Viruses on the Dendritic (Langerhans') Cells of the Human Anal Mucosa
Sobhani et al.
Clin. Cancer Res. 2002;8:2862-2869.
ABSTRACT
| FULL TEXT
Cell-Mediated Immune Response to Human Papillomavirus Infection
Scott et al.
CVI 2001;8:209-220.
FULL TEXT
Preventive Health Care for Adults With HIV Infection
Jewett and Hecht
JAMA 1993;269:1144-1153.
ABSTRACT
|
